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Background: Many countries have devoted considerable efforts in an attempt to improve the performance of their
health care systems. National Medical Associations (NMAs), along with other stakeholders, play a part in the
promotion of such activities. The purpose of this paper is to explore the nature and level of participation of NMAs
in activities of quality improvement in medicine, with a specific emphasis on Israel.
Methods: The authors conducted a survey among NMAs around the world inquiring as to their involvement in
three central aspects of quality improvement: clinical guidelines, quality measurement and continuing medical
education (CME). In addition, they conducted a review of the literature in order to gather more information and
complete the data collected in the survey. The findings were processed and analyzed comparatively.
Results: Most of the NMAs surveyed participate in quality improvement activities at least to some extent. NMAs'
main involvement is in the regulation of CME and they are involved to a much lesser extent in the preparation of
clinical guidelines and in quality measurement. In Israel, the Israeli Medical Association (IMA) has a dominant role in
both the preparation of clinical guidelines and the regulation of CME credits.
Discussion: It is possible that the expertise maintained by the profession, coupled with the organizational power of
the NMA as a union, is viewed as beneficial for regulating educational activities in medicine such as CME.
Conversely, the issuing of clinical guidelines is usually regarded as a typical scientific activity, and therefore often
rests in the hands of professional medical societies. Quality measurement is regarded as a distinctive administrative
tool and is usually found in the province of governments. Based on the typology that we introduced in our
previous paper, we discovered that the extent of NMAs’ involvement in quality improvement coincides with the
mode of governance of the health care system.
Conclusions: The nature and level of participation of NMAs in activities of quality improvement varies widely.
Collaboration of NMAs in this field with other stakeholders is not uncommon, and may contribute to the further
development of quality improvement in medicine.Introduction
There is growing interest in the various forms of task shar-
ing between governments and other stake holders in
health care systems, among them national medical associ-
ations (NMAs) [1-6]. Although an NMA may traditionally
serve as a trade union, it may also take upon itself ad-
ditional roles and serve as a professional standards setter,
policy maker, ethical arbiter, disciplinarian, or some com-
bination of the above.* Correspondence: baruch@ima.org.il
The Israeli Medical Association (IMA), Ramat Gan, Israel
© 2014 Levi et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.In a recent IJHPR article, we explored the role of the
NMA as regulator of the medical profession, and the
division of labor between the association and the
government [1]. In this article, we seek to document its
place in another key area - that of quality improvement.
This realm, like that of public policy which we hope to
explore in a third and final article, is a later addition to
the ambit of professional activity.
In this article, we seek to determine in which activities
of quality improvement different NMAs participate, and
to what extent. We refer to the same framework of. This is an Open Access article distributed under the terms of the Creative
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ous paper - corporatist, market or hybrid systems. We
posit that the structure in each country influences
NMA involvement in quality improvement in the same
manner, although not necessarily to the same extent, as
it does more traditional regulatory activities such as
licensing and specialty training.
The promotion of quality improvement - background and
literature review
Quality improvement in medicine can be described as a
general effort to create a system of scientific, organizational
and administrative activities designed to promote the im-
provement of healthcare services. In recent decades, many
countries have devoted considerable efforts in an attempt
to improve the performance of their health care systems.
These efforts can be seen in a range of scientific, orga-
nizational, administrative and financial activities grouped
under the heading of “quality assurance” or “quality im-
provement”. Policy makers, health authorities, health pro-
viders, insurers, associations of physicians and other health
workers, as well as private and public bodies, are involved
in continued and complex processes whose purpose is to
ensure the quality of clinical treatment in particular, and
the function of the health system as a whole [2].
Governments around the globe no longer confine them-
selves to the role of passive payers. Their gradual awareness
of issues of efficiency and effectiveness has led them to
search for ways to “ensure value for money”. Through qual-
ity improvement activities, governments seek to derive
maximum medical benefit from the health care system
under existing budgetary constraints. In this way, the ultim-
ate goal of these activities – improving public health – is
accompanied by an economic objective: to curb soaring
health costs, while making the system more efficient.
Following the rapid spread of quality improvement
activities in Israel and worldwide, and in light of their
enormous importance to the government in recent years,
the issue of allocating responsibility for their implementa-
tion has been placed on the agenda, and with it, the ques-
tion of the medical association's role in promoting these
activities. Several reports and surveys performed by re-
search institutes and international organizations like the
World Health Organization (WHO) and the Organization
for Economic Cooperation and Development (OECD)
have addressed the issue of medical regulation and the
division of responsibilities between stakeholders. These
works indicate the large number of bodies involved in
regulatory tasks and the complexity of the regulation of
health care systems [2-4]. However, although many parties
might engage in quality improvement, not all are equipped
to do so in an optimal fashion.
Legido-Quigley and colleagues discovered that clinical
quality schemes that include, inter alia, clinical guidelines,quality measures, information systems and audit processes,
often involve the development of new organizational
structures, processes, measurement tools or methods [5].
De Vries and colleagues, who examined the regulation of
ten health care systems around the world, state that the
bodies responsible for regulation and quality assurance of
medical education vary from country to country [4]. In
particular, they examine different approaches to continu-
ous professional development (CPD) and conclude that
they vary widely. In Spain and Germany, for example,
CPD is one of the main areas of activities engaged in by
the provincial medical colleges and regional chambers of
doctors, which often provide training courses and related
services. In South Africa, this responsibility is entrusted in
the hands of the Health Professionals Council of South
Africa (HPCSA), which is the key medical regulation body
in the country [4]. A similar picture of diversity and com-
plexity regarding the regulation of continuing medical
education is present in the WHO report on regulation and
licensing of physicians from 2005 [6].
Or investigated initiatives to better measure and im-
prove performance of health care systems in four OECD
countries (France, the Netherlands, New Zealand and
Sweden), describing in her work the role of institutional
arrangements as well as policy and management “levers”
used to bring about change in this field. The difference
in the countries' approaches to the issue of quality im-
provement can be illustrated in the following example:
In the Netherlands, health care providers have tradition-
ally borne the primary responsibility for controlling and
improving the quality of services provided. They are dir-
ectly responsible for developing quality control systems,
with explicit norms and procedures, and the government
plays an active role in supporting these self-regulatory
activities through a national policy for quality manage-
ment. The government also holds a national conference
every five years with healthcare providers, financers, and
patient organizations in order to evaluate improvements
and create consensus for new activities. The national
health policy stresses that quality management is the
joint responsibility of health care professionals and man-
agement [3].
On the other hand, in France, the State has much more
responsibility for assuring the quality and efficiency of
both primary and secondary care, employing a number of
tools such as hospital accreditation, financial incentives
and sanctions, and mandatory guidelines. France is one
of the few countries which tried to impose mandatory
clinical guidelines for medical practice. Although self-
regulation in France continues to work in traditional
ways, with private physicians being paid on a fee-for-
service basis and patients having free access to any
physician, the government does involve itself in the pro-
fession's medical autonomy with regard to activities of
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ical guidelines [3].
Improving health care quality through medical educa-
tion is also on the agenda in different countries. In the
USA, a shared educational initiative of the American
Medical Association (AMA) and 11 medical schools is
currently being implemented. Its main target is to shift
the focus of medical education toward performance im-
provement, concentrating on chronic care, teamwork,
population health, and community [7]. In Israel, courses
on patient safety and health policy issues have been in-
troduced to the curriculum of undergraduate medical
students at the Hebrew University of Jerusalem [8]. In
addition, continuing medical education (CME) programs
are evolving globally in order to enhance health profes-
sionals’ knowledge and skills [9].
The efforts described above to map and clarify the
various approaches and models of medical regulation
have contributed tremendously to the understanding of
global developments taking place in the area of quality
improvement. Nonetheless, although random and spor-
adic references to NMAs can be found in current litera-
ture, we feel that more information regarding the role of
NMAs in this issue should be gathered and systematic-
ally analyzed.
As stated in our previous work, the role of the NMA
is multi-faceted. With the development and expansion
of the medical world, most NMAs no longer view them-
selves solely as trade unions, if at all. Therefore, it is
valuable to examine the extent and nature of their inter-
vention in the improvement of health care systems.
Methods
While the nominal definition of “quality improvement”
offered in the previous section helps in clarifying its
nature and boundaries in general terms, in order to
achieve a more operational definition of “quality im-
provement” one must identify its more dominant and
measurable aspects.
The literature on quality improvement deals with a
variety of different and important activities intended to
advance the quality of health care. Although improving
the professional capacity of physicians and other health
professionals is a most desirable goal, quality improvement
efforts are not limited to this purpose alone. Some quality
improvement activities focus on the organizational level,
such as the accreditation of hospital departments or the
computerization of patient records [3]. Others concentrate
on patient education and promote patients’ active involve-
ment in shared decision making and access to information
[5]. Financial incentives, regulation and policy strategies
such as changes in reimbursement schemes or setting
licensure requirements, can also be regarded as strategies
of quality improvement on a more systematic level [5,6].Many quality improvement strategies have been insti-
tutionalized in healthcare systems around the world.
Three of them are mentioned repeatedly in white papers
and international reviews issued by the OECD and
WHO, as well as by national governments and various
bodies of research: clinical guidelines, quality measure-
ment and continuing medical education [2,5,6,9].
It is important to mention, in the Israeli context, that
the Division of Medical Policy of the Israeli Medical
Association considers these three activities to be at the
core of clinical medical practice and engages in their
promotion, while encouraging physicians to take part in
their development [10].
These three core activities can be defined as follows:
 Clinical Guidelines – systematically developed
statements to assist practitioner and patient
decisions about appropriate treatment in specific
clinical circumstances [11].
 Quality measurement - a mechanism that enables
the quantification of the quality of a selected aspect of
care, by comparing it to an evidence-based criterion
that specifies what is better quality [12].
 Continuing Medical Education (CME) – a set of
educational activities that serve to maintain, develop
and increase the knowledge, skills and professional
performance a physician uses when providing services
for patients, the public, or the profession [13].
The involvement of NMAs can take many forms. It can
be direct or indirect. It can be manifested in declarations
and the publication of position papers, or in more active
participation in the public and professional discourse
through lobbying or other forms of pressure. It can be lim-
ited to formal representation in steering committees, or it
may take a wider approach, such as the initiation and
organization of conventions and academic courses. It is
safe to say that almost all NMAs are involved at least to
some extent in quality improvement. Nevertheless, a more
rigorous approach is needed in order to be able to address
the issue in a quantifiable and analytical fashion.
Similar to the method used in our previous work, we
created a scale of four degrees between zero to three,
with which to measure the scope of involvement of
NMAs in quality improvement. The scale reflects the
aggregate number of activities engaged in by NMAs as
the prominent or leading body, in cooperation with
another entity or exclusively (for instance, through dele-
gation of responsibilities). Sometimes the administration
and the medical profession share responsibility for regu-
lating these activities, but often it is possible to point to
one of them as the principal authority, or at least as the
most prominent– usually the body that initiates the
activity, executes it or supervises its execution by others.
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NMA’s involvement in quality improvement. We also
categorized NMAs according to their involvement in
each of the three activities examined, in order to deter-
mine in which they are more likely to participate.
A questionnaire dealing with the involvement of medical
associations in the improvement of quality was distributed
by email to the 102 NMA members (at the time) of the
World Medical Association (WMA), with the assistance
of the WMA staffa.
The questionnaire asked the following questions:
a. Who is responsible for issuing clinical guidelines? Is it
a governmental or medical-professional body (medical
association/society/chamber)? What is the role of the
medical association (if any)?
b. What is the role of the profession in the regulation of
performance measurement? Is this led by a
governmental or medical-professional body? Is the
medical association itself involved in this activity?
c. Is Continued Medical Education (CME/CPD)
voluntary or mandatory for physicians in your
country? (Mandatory = linked to re-licensure/
re-validation/renewal of license etc.)
d. Who is responsible for administering CME credits in
your country? Is this run by the profession?
Where no reference is given in the text, the information
stated was obtained from one of the surveys received.
In addition, we conducted a review of the literature,
using search engines such as Google, Google-scholar
and PubMed, in order to gather more information and
complete the data collected in the survey. The findings
were processed and analyzed comparatively.
22 countries responded to the questionnaire and are
included in the comparative analysis given below: Albania,
Australia, Belgium, Canada, China, Croatia, Denmark,
Ethiopia, Germany, Hong Kong, Iceland, Israel, Kazakhstan,
the Netherlands, New Zealand, Serbia, South Korea, Spain,
Sweden, Taiwan, United Kingdom, United States.
The validity of study results may be affected by the
low response rate (22%). Although not uncommon in
WMA surveys of this sort, this low rate may reflect a
possible bias in that NMAs that are more involved in
quality improvement or work in systems that promote
quality improvement may be more inclined to partici-
pate in the survey than other NMAs. A more effective
way to encourage associations to respond to such ques-
tionnaires should be considered.
Without wishing to dismiss the contribution and import-
ance of employers, insurers, pharmaceutical companies
and other health organizations, we shall focus in this docu-
ment on the role of medical associations vis-à-vis the gov-
ernment and scientific bodies that operate independentlyin the regulation of quality improvement activity. However,
it should be noted that we did not examine the actual ap-
plication of these activities in practice in every country, as
this task is beyond the scope of this article. Theoretically,
an NMA may be involved in three activities out of three,
but in practice, none of these activities has any significance
in that particular health system. On the other hand, an
NMA may be in charge of one activity only (for example,
quality measurement), but that particular activity may play
a significant role in the relevant health care system. In that
case, it is not clear at all which NMA has a more signifi-
cant role, practically, in quality improvement. This may be
considered a major constraint of our work for those who
wish to learn more about the actual scope of quality im-
provement activity in different health systems. Neverthe-
less, the prime goal of our study is to describe the formal
division of responsibilities among the government, the
NMA and the various scientific bodies with respect to the
three tools of quality improvement described above. We
feel that a study of this kind could offer a good starting
point for further studies focusing on the division of respon-
sibilities in practice, and correlating the extent to which
they align with the bureaucratic frameworks depicted in
this paper.Results
The involvement of NMAs in quality improvement will
be examined according to two aspects. First, as shown in
the following figure, NMAs are categorized according to
their total participation in the activities examined. Later,
the NMAs will be categorized according to the their par-
ticipation in each of the individual activities, in order to
determine in which activities NMAs are more involved.
The tables will be followed by examples from several
countries that participated in the survey (Table 1).
More than half of the NMAs surveyed have formal
roles in quality improvement activities to varying degrees
(12/22). Most notable are Germany and China, where
the medical associations are involved in all three forms
of quality improvement. Half of the 12 NMAs that par-
ticipate in quality improvement, do so only to a minimal
extent (degree of participation = 1), and are usually in-
volved in CMEb (Figure 1).
The graph shows that half of the NMAs participating
in the survey are involved in CME in their countries
(11/22): Belgium, China, Croatia, Germany, Hong Kong,
Israel, the Netherlands, South Korea, Spain, Taiwan, USA.
Only approximately one-fifth of the NMAs are en-
gaged in the production of clinical guidelines (5/22) and
quality measurement (4/22):
Clinical Guidelines: Belgium, China, Germany, Israel,
Spain
Quality measurement: Albania, China, Germany, Taiwan






2 Belgium, Israel, Spain, Taiwan
1 Albania, Croatia, Hong Kong, South Korea, The
Netherlands, USA
0 Australia, Canada, Denmark, Ethiopia, Iceland,
Kazakhstan, New Zealand, Serbia, Sweden, UK
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bodies other than NMAs: scientific bodies (generally
specialists’ associations) tend to focus on the develop-
ment of clinical guidelines, while quality measurement is
generally regulated by the government or a governmen-
tal agency.
As stated above we have separated quality improve-
ment into three areas of work: clinical guidelines, quality
measurement and continuing medical education. Each
task will be reviewed independently, comparing the
division of responsibilities between the profession and
the government in a range of countries, based on the
result of our survey and independent research.
Clinical guidelines
The production of clinical guidelines has become an
increasingly common part of clinical practice. There is
great diversity among countries as to who is responsible
for producing such guidelines and, even within certain
countries, this practice is often conducted by several
different bodies.
In Israel, as in many other countries, the responsibility
for preparing clinical guidelines rests with professional
scientific societies. These societies, also referred to as
medical societies, are comprised of physicians in specific
fields of specialization and focus on the scientific and
clinical aspects of the profession. They may be, but areFigure 1 Categorization of NMA participation in quality
improvement.not always, part of the NMA. The Israeli Medical Asso-
ciation (IMA) acts as the umbrella association for its
scientific societies and supports and encourages their
activities. The IMA's Division of Medical Policy reviews
the guidelines and assists with their preparation, publi-
cation and distribution to physicians in Israel. In addition,
the Israeli Ministry of Health prepares clinical guidelines,
in the form of circulars, through its advisory National
Councils. The health funds also formulate their own
internal guidelines.
Likewise, clinical guidelines in South Korea are mostly
produced by the various scientific societies; however, the
medical association noted that the government is increas-
ing its input into the development of clinical guidelines.
The German medical community has a long tradition of
self regulation, whereby the medical association and cham-
bers perform an important regulatory role. The German
Medical Association (GMA) is involved in the preparation
of clinical guidelines through a number of its agencies,
such as the Drug Commission, a scientific committee of
experts in the field of pharmaceuticals, or the Scientific
Advisory Board of the GMA, which consists of scientists
representing all medical disciplines. The German Agency
for Quality in Medicine (AQuMed), a non-profit orga-
nization established in 1995 by the GMA, and the National
Association of Statutory Health Insurance Physicians, also
participate in the preparation of clinical guidelines. These
bodies prepare programs to promote quality in the
health system, focusing on evidence based medicine
(EBM), clinical guidelines, patient empowerment, treat-
ment safety and quality management.
By way of contrast, in Iceland, the governmental Office
of the Surgeon General is responsible for issuing clinical
guidelines. Although the medical association was par-
tially instrumental in establishing this service, it is not
involved in any way in the day to day work.
In England, the National Institute for Health and Clinical
Excellence (NICE) is responsible for developing clinical
guidelines. They do so without the involvement of the
British Medical Association (BMA). NICE was estab-
lished in primary legislation as a Non Departmental
Public Body in April 2013. The Department of Health
instructs NICE to prepare guidelines in specific areas of
health and assessments of medical technologies.
The Ministry of Health of the Republic of Kazakhstan
is responsible for developing clinical guidelines in that
country, in consultation with the National Medical Asso-
ciation. The governmental body develops draft guide-
lines and distributes these documents to the National
Medical Association, which consults with its different
branches before commenting.
It seems that NMAs are generally only marginally
involved in the preparation of clinical guidelines, if at all.
Examples like the IMA and the GMA are few, and in
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this aspect of quality performance activity.
Quality measurement
There is an ever-growing demand from the public, health-
care providers, regulatory agencies and the government,
for evidence based quality measurement. Quality improve-
ment has become part of the everyday routine of many
healthcare professionals [14].
In Israel, the Ministry of Health runs a national quality
measurement program in the community with the
cooperation of the four health funds [15]. In addition,
the Ministry has begun a project to measure the out-
comes of hospital care. This program is managed by a
review committee appointed by the Director General
of the Ministry of Health [16].
In the Netherlands, the Health Care Inspectorate
(HCI), a government body, is responsible for developing
measures of quality. The HCI works in conjunction with
relevant professional bodies, including associations
of specialists and general practitioners, as well as the
Hospitals Association. Similarly, in New Zealand the
government is primarily responsible for quality meas-
urement through the Medical Council of New Zealand
(MCNZ), a regulatory body. The MCNZ requires doc-
tors to be fit to practice. District health boards measure
and regulate performance through physician employ-
ment agreements or through funding requirements for
general practice. The MCNZ Good Medical Practice
publication provides guidance to doctors on the stan-
dards of practise which the MCNZ expects. The Health
Practitioners Disciplinary Tribunal, the Council's Profes-
sional Conduct Committees and the Health and Disability
Commissioner can (but are not required to) use this publi-
cation as a standard by which to measure professional
conduct [17]. The medical profession also plays a role in
the regulation of performance measurement. In particular,
the Medical Colleges have various certification require-
ments for doctors, such as Cornerstone, an auditing
tool for practices, established by the Royal NZ College
of General Practice.
In Hong Kong, the performance of the medical profes-
sion is regulated and measured by the Medical Council
of Hong Kong, a judicial body created under the Medical
Registration Ordinance. The performance of the univer-
sities in Hong Kong is also under the scrutiny of the
Education and Accrediting Committee of the Medical
Council of Hong Kong.
While in the Netherlands, New Zealand and Hong
Kong the medical profession (as opposed to the NMA
itself ) is in some way involved with their respective
governments' regulation of quality measure, in Spain per-
formance measurement is led by the government and the
medical association is not involved at all.In the United States there are several entities engaged
in quality measurement – the government and its agen-
cies, insurers, health service providers and scientific
organizations. However, most activity takes place within
the framework of joint initiatives by health service pro-
viders and government bodies [18]. Prominent among the
government bodies is the Agency for Healthcare Research
and Quality (AHRQ), which publishes an annual health
index pursuant to the Healthcare Research and Quality
Act 1999 [19]. The existence of a federal law indicates the
importance that the United States places on health meas-
urement, which includes measures of quality in medicine.
The AHRQ works alongside the Center for Medicare and
Medicaid Services (CMS), the National Quality Forum
(NQF) and other bodies at the federal and state level
responsible for promoting quality in the health system.
Among their activities is the creation of financial mech-
anisms that link physicians’ pay to their performance
[18]. The CMS is increasingly involved in quality meas-
urement and has created several quality initiatives in-
cluding: quality improvement, pay for reporting, and
public reporting. CMS has also established a standardized
system for developing and maintaining the measures used
in its quality initiatives, known as the Measures Manage-
ment System (MMS). This system is composed of a set of
business processes and decision criteria that CMS funded
measure developers follow in the development, implemen-
tation, and maintenance of quality measures.
The National Quality Forum (NQF) reviews, endorses,
and recommends use of standardized healthcare per-
formance measures and has endorsed the measures
developed by the CMS Measures Management System
[20]. The Physician’s Consortium for Performance Im-
provement (PCPI) is another entity, convened by the
AMA, that works to develop evidence-based measures
of clinical performance. It also provides resources for
physicians to use as they become familiar with performance
measurement. Members of PCPI include state medical soci-
eties, national medical specialty societies, AHRQ, CMS, the
American Board of Medical Specialties and the Council of
Medical Specialty Societies [18].
In Germany, the medical association oversees quality
measurement. In September 2000, the German Medical
Association (GMA), together with the Hospitals’ Federation
and a number of insurers, set up the Institute for Quality
and Patient Safety (BQS), which acts as an independent
institute for the development of quality measures. In
addition, the medical association and other bodies
sponsor the “Forum Gesundheitsziele”, which works to
develop national standards for health services. The
GMA also works with the Agency of Health Technology
Assessment (DAHTA) to publish reports on assess-
ments of medical technologies. Another body that
works in cooperation with the medical association on
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Quality and Efficiency in Health Care, an independent
body that studies the benefits and harm to patients
following medical treatments.
In summary, the responsibility for quality measure-
ment differs among the countries reviewed. In some
cases non-governmental bodies, such as medical soci-
eties and NMAs, participate in the development of
quality measures. In most cases, however, it is the gov-
ernment, sometimes via a designated entity, that is the
most prominent stakeholder in this aspect of quality
improvement.
Continuing Medical Education (CME)
A great challenge for physicians today is staying abreast
of the relevant material in their specific medical spe-
cialty. With new technology and scientific research,
medicine is rapidly changing and medical education does
not end with formal training [21]. The importance of
continuing medical education is demonstrated by the
many countries that have made it a mandatory require-
ment for their physicians (Figure 2).
As shown by the graph above, CME is mandatory in
most of the surveyed countries, and is often linked to
the renewal of physicians’ licensesc.
Mandatory CME: Albania, Australia, Canada, China,
Croatia, Germany, Hong Kong, Kazakhstan, the Netherlands,
New Zealand, Serbia, South Korea, Taiwan, UK, USAd.
Voluntary CME: Belgium, Denmark, Ethiopia, Iceland,
Israel, Spain, Sweden
It is worth emphasizing that the role of NMAs in the
area of CME is not limited to the provision of credits,
but often includes the authority to decide which activ-
ities will be recognized for CME credits, their content
and their contribution to the overall CME scheme. In
other words, NMAs are not involved merely in the tech-
nical aspect of administering credits, but also help deter-
mine the quality standard of CME.
One question that needs to be addressed is the effect-
iveness of CME in improving the quality of care. Despite
the generally low quality of evidence in existing studies,
these studies suggest that CME is effective, at least toFigure 2 CME activity.some degree, in improving the quality of care, especially
when using interactive CME interventions such as
conferences, courses, rounds, meetings, symposia and
lectures [22-24].
In Israel, CME is undertaken on a voluntary basis. The
health funds, hospitals, and scientific associations run
professional refresher courses and workshops, and the
IMA is responsible for granting credits for recognized
activities. However, only a small minority of physicians
routinely engage in formal CME activities.
The Royal Dutch Medical Association is responsible
for CME in the Netherlands. Its subsidiary, the Central
College of Specialists, manages continuing medical edu-
cation and license renewal for specialists. The medical
association controls and supervises these activities, and
healthcare professionals earn credit for participation [25].
Since 1991, the Dutch Central College of Specialists
has managed a system to renew the registration of spe-
cialist physicians, on behalf of 27 scientific associations.
One requirement for renewal of registration is that every
specialist in the country participates in 40 hours of rec-
ognized CME activity [2].
Similarly, in Germany, the German Medical Associa-
tion's Regulation Framework for Continuing Medical
Education serves as a model regulatory procedure for
the State Medical Chambers. Continuing education
activities are only recognized by the Chambers if they
correspond to the requirements set out in the Medical
Association's Regulation Framework [26].
In Taiwan, CME is mandatory and is run by the medical
profession. The Taiwan Medical Association, Formosan
Medical Association, Taiwan Association of Family
Medicine, and the Taiwan Pediatric Association are
responsible for administering CME credits in Taiwan.
In the United Kingdom, CME is largely run by the
scientific associations and institutions of the General
Medical Council (GMC), a non-governmental regula-
tory body, with independent statutory statuse. After
lengthy policy consideration, continuing professional
education is now a binding condition for renewal of
licenses to practice medicine [27].
In Canada, "Maintenance of Competence" require-
ments, which are CME based, are administered through
the educational bodies: the Royal College of Physicians
and Surgeons of Canada and the College of Family Phy-
sicians of Canada. The Canadian Medical Association is
not involved in these activities, although it communi-
cates regularly with the organizations that are involved
and makes the views of its members well known.
In Australia the practice is similar to that in Canada.
CPD/CME credits are issued by the medical colleges,
which have a framework for accrediting material eligible
for CPD credits or “points”. These points may be used
by the participating doctor towards his or her annual
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medical registration. The material is often delivered by
College accredited education providers, rather than the
College itself, and the content of the program must meet
College accreditation requirements in order to qualify.
The Australian Medical Association (State or Federal)
can therefore deliver CME/CPD programs assuming
they are College accredited providers.
With the recent introduction of the national medical
registration, administered by the governmental Austra-
lian Health Professional Regulation Agency, physicians
must report and record their participation in ongoing
CPD as a requirement for medical registration. While
the Australian Medical Association is not involved in
performance measurement, it is considering providing a
service to members by recording CPD.
In Serbia, CME is mandatory. The National Healthcare
Council of the Republic of Serbia, which is elected by
the National Parliament, is responsible for accreditation
of CME programs, and members of Serbian Medical
Chamber’s Assembly are involved in a special task group
on CME. In contrast, in Sweden and Denmark, CME is
not formalized at all and there is no requirement for
medical professionals to partake in it.
In the United States, while CME is mandatory in the
majority of states, Colorado, Indiana, Montana and
South Dakota are the exception. The requirements of
the different states also vary greatly, with the minimum
hours of CME required ranging from 16 to over 100
hours [28]. The Accreditation Council for Continuing
Medical Education (ACCME) is responsible for accredit-
ing US institutions offering CME and their accreditation
system is recognised as a national model by federal and
state government agencies. The American Medical Asso-
ciation is one of the founding members of the ACCME,
together with the American Board of Medical Specialties,
the American Hospital Association, the Association of
American Medical Colleges, the Association for Hospital
Medical Education, the Council of Medical Specialty Soci-
eties, and the Federation of State Medical Boards of the
United States. The seven founding members are also regu-
larly involved with the regulation of the ACCME. Their
duties include nominating individuals to the Board of
Directors, providing input into ACCME’s strategic direc-
tions, and overseeing the ACCME actions and bylaws
changes [29]. The AMA also provides some CME pro-
grams for physicians and offers a Physician's Recognition
Award (PRA) which recognizes physicians who have
earned an average of 50 credits per year from educational
activities that meet AMA standards.
As seen from our survey findings, national medical
associations are more likely to be involved in CME than
in other areas of quality improvement. Nevertheless, in
many cases they are not solely responsible for thispractice. In many countries reviewed, such as Canada
and Australia, CME is administered by educational bodies.
Israel case study
As in other countries, health authorities in Israel invest
considerable efforts in developing quality improvement
activities. Their development has been accelerated during
the last decade with the launching of quality measurement
projects in primary care and the proliferation of clinical
guidelines, both of which have seemingly gained the sup-
port of the medical community. On the other hand,
mandatory CME has not been realized so far, despite the
intention of the Ministry of Health. Although Israel is not
considered unique in this regard, it has yet to join to the
global trend of turning CME mandatory.
Development of clinical guidelines
In Israel, the responsibility for preparing clinical guide-
lines rests with the scientific associations, which bear
the responsibility for developing the theory of clinical
work. The IMA supports this activity, and encourages its
associations and physicians to write guidelines. The
IMA's Medical Policy Division assists with the prepar-
ation, publication and distribution of these guidelines to
doctors. The Division also reviews the standard of evi-
dence on which guidelines are based, ensuring that they
comply with the rules of Evidence Based Medicine
(EBM) and cost effectiveness and that they do not con-
flict with other guidelines or instructions on the same
subjects. The guidelines can be found both on the IMA
website and that of the relevant scientific association,
and bear the stamp of the IMA and of the association/s
that participated in writing them. The health funds and
hospitals that adopt the guidelines distribute them to
their physicians.
It should be noted that the Ministry of Health also initi-
ates the writing of guidelines through its circulars. Apart
from the clinical guidelines of the IMA and its scientific
associations, and the Ministry circulars, the health funds
distribute their own internal guidelines.
Comprehensive research conducted in Israel in 2005
that dealt with the implementation of clinical guidelines
among community physicians showed that the majority
of physicians express a high to very high level of agree-
ment with the assertion that clinical guidelines improve
the quality of care (73%) and contribute to better clinical
outcomes (62%). In addition, IMA’s position as a distri-
buter of the guidelines among other stakeholders and its
recommendations to physicians to make use of them,
were speculated by the researchers as contributing to
their acceptance by physicians. Nonetheless, it should be
mentioned that Israeli physicians tend to adhere only
partially to the guidelines, due, among other things,
to structural barriers such as lack of time, workforce
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that this study was conducted almost ten years ago, it
does not conclusively represent the attitude of today's
physicians.
Quality measurement
The main activity in the field of quality measurement in
Israel has been carried out in community medicine for
more than a decade. The Israeli program for quality meas-
urement in community medicine began as a research ini-
tiative at Ben Gurion University in Be'er Sheba. The study
was later expanded into a national program, in conjunc-
tion with the four health service providers, the support of
the IMA, and under the auspices of the Israel National
Institute for Health Policy Research. In 2004, the Ministry
of Health declared the activity to be a national, permanent
and established program, and in recent years it has taken
over responsibility for its execution [15].
The program focuses on measurements in a number
of important areas, such as preventive drug treatment
for asthma, screening for breast and colon cancer, vacci-
nations against influenza and pneumococcus for adults,
treatment of diabetes, and prevention and treatment of
cardiovascular diseases. The aims of the national pro-
gram are to improve the quality of community health
services in Israel, and to provide the public and policy
makers with information on this subject. At the same
time, it has drawn criticism from doctors and associa-
tions, who argue that the program is managed by the
health service providers in a way that does not always
serve the patients’ interests. Many indicators in the pro-
gram are performance measures that examine how physi-
cians meet specific quantitative objectives (for example,
the percentage of patients who are treated with medica-
tion for asthma or who have undergone mammography),
without demonstrating the quality of the therapeutic
process in terms of medical benefit (how effective is the
medication in reducing asthma seizures? To what extent,
if at all, has the increase in mammography contributed to
breast cancer survival rates?). In addition, it is argued that
health provider managements exert pressure on physicians
to meet set targets, without considering the suitability of
these targets to actual clinical reality [31].
Nevertheless, research from 2012 has shown that most
primary care physicians (87%) in Israel felt that the mon-
itoring of quality was important and two-thirds (66%)
felt that the feedback and subsequent remedial interven-
tions improved medical care to a great extent. The research
indicates that only a minority of physicians oppose the
monitoring program [32].
In addition to the community program, the Ministry
of Health is currently planning a program to measure the
outcomes of hospital care. This project began four years
ago, and is managed by a review committee appointed bythe Director General of the Ministry, and funded from the
Ministry budget. The initial database contained surgical
procedures from 2001 to 2008 in 26 general hospitals in
Israel. As of 2010, it included repeat surveys of 24 depart-
ments of general surgery and 27 orthopedic wards. The
activity involved a survey of outcome and process indica-
tors used in quality measurement projects worldwide,
such as infection of surgical wounds, rate of pneumonia
among patients given artificial respiration, unplanned
returns to the operating theater, complications during and
after surgery, complications after release from the hospital,
repeat hospitalization and others [16].
Discussion of the Israeli case would not be complete
without reference to the IMA opposition to early efforts
on the part of the Ministry of Health to impose quality
measurement. In early 1994, the Ministry of Health
established a Quality Assurance (QA) Division. The IMA
requested to be included in the policy making and
instructed its member physicians not to participate in
surveys carried out by the Division. The Ministry's
ability to carry out surveys and impose quality standards
was thus severely limited. The IMA's concern was that
without proper safeguards of confidentiality, the process
would be used to harm the physicians, rather than
improve quality. Indeed, in 1995 a scandal erupted
when the results of quality measurement surveys were
leaked to the press. The surveys indicated controversial
results of excessive mortality rates in heart surgeries in
certain hospitals. As a result of the publication, the
Ministry of Health stopped the comparative measure-
ments and reduced the activity of its QA division [33].
In 1997, a treaty was signed between the IMA and the
Ministry that, among other provisions, stated that issues
relating to quality surveys would be decided between
both parties. Officials in the Israeli health care system
claimed that this cooperation between the ministry and
the IMA “buried” the quality surveys initiative [34]. The
IMA later maintained that the treaty was not adhered to,
and, in addition, other QA activities continued without
the input of the IMA. Therefore the treaty was essentially
impotent. Nonetheless, the IMA stands behind the im-
portance of QA activities, provided they do not result
in injury to the physicians.
CME
Doctors in Israel are not currently required to renew
their licenses, but there is a non-binding process of profes-
sional updating within the health funds and hospitals, and
as an initiative of the scientific associations, which run
professional refresher courses and workshops. The IMA
grants credits for recognized activities, but they are not
linked to renewal of licensing/ registration at this stage.
It should be noted that in June 2008 the Ministry of
Health announced its intention of promoting re-registration
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Ministry every few years as a condition of practicing
medicine. According to the media, the ministerial com-
mittee discussing this subject raised a number of op-
tions– from purely administrative registration to the
possibility of pre-conditions for license renewal, includ-
ing exams, quality control and reporting of complaints
and negligence claims [35]. This announcement aroused
the opposition of the IMA and as of now CME is still
voluntary in Israel and only a small minority of physicians
engages in this activity routinely, due to lack of positive or
negative incentives to do so.
We see that the IMA is responsible for the adminis-
tration of CME credits and for the preparation and pro-
liferation of clinical guidelines, with the collaboration
of the medical societies. On the other hand, it has no
apparent formal role in the ongoing project of quality
measurement in primary care, although its support was
obtained in order to ignite the move at the beginning of
the millennium. In addition, it seems there is extensive
physician support for quality measurement and the issu-
ing of clinical guidelines, as physicians acknowledge
their importance to the improvement of clinical care. It
can be assumed that this support has a positive effect
on the feasibility of these activities and enables their
continuation and further development.
Discussion
One of the most noteworthy findings of the survey we
conducted is that NMAs tend to focus on CME more
than on other aspects of quality improvement.
Why are NMAs involved in CME predominantly more
than they are involved in other areas of quality improve-
ment? Should they be taking a more active role in other
quality improvement activities?
One may speculate that the role of NMAs in CME
activities is linked to their position in the previous stage of
medical education – specialty training. In our previous
work on regulatory tasks we examined health systems in
five countries: Germany, Israel, the Netherlands, USA and
the UK and compared the involvement of NMAs in
specialty training, among other areas [1]. The research
revealed that in three countries (Germany, Israel and
the Netherlands) the NMA is the body responsible for
specialty training. Thus it seems no coincidence that in
these three countries the NMAs also play a central role
in CME.
In the UK, on the other hand, CME credits are admin-
istered by the Medical Royal Colleges and not by the
NMA, which similarly holds no responsibility for spe-
cialty training. The AMA is an exception on this matter,
being the only NMA among the five examined that
refrains from regulating specialty training on one hand,
but fulfills a prominent role in CME on the other hand.In Israel and in the USA, the NMA administers the recog-
nition and accreditation of educational activities necessary
for the completion of learning cycles (for example, in
Israel, the accumulation of at least 200 CME points in
every 2 years). Despite the difference in the standing of
the CME system in both countries (mandatory and linked
to re-licensure in most states in the USA and completely
voluntary in Israel), it seems that the position filled by the
NMA in both countries with regards to CME is similar,
and may reflect the dominance of NMAs in the regulation
of educational processes around the world.
In light of these findings, it seems reasonable to
assume that the same logic that drives governments to
delegate the regulation of specialty training to the NMAs,
leads them also to entrust NMAs with the regulation of
CME; the expertise maintained by the profession, coupled
with the organizational power of the NMA as a union, is
apparently regarded as a useful tool in regulating educa-
tional activities in medicine, and, as stated in our previous
work, “setting the limits to governmental involvement in
’higher’ levels of medical professionalism” [1].
Whereas the regulation of CME comprises both scien-
tific and organizational aspects, the issuance of clinical
guidelines is mainly centered on “pure” scientific effort
with lesser organizational intervention. The gathering of
medical data, the evaluation of evidence and the careful
elaboration of clinical recommendations are consid-
ered sequential stages of a scientific process best left to
experts. As opposed to CME programs, the use of clinical
guidelines is not usually linked to a formal regulatory
mechanism and is not routinely supervised or systematic-
ally organized as a mandatory activity. This may serve to
explain why so few NMAs are involved in clinical guide-
lines, and why they are instead left largely to scientific
societies and colleges, with or without the involvement of
health ministries or agencies.
Israel is one of the few countries where the NMA is
involved in the issuing of clinical guidelines. A possible
explanation for this is the structural relationship be-
tween the IMA and the medical societies, wherein the
societies are actually part of the IMA hierarchy, with
no formal independent standing or legal status of their
own. The symbiosis between the IMA and the medical
societies in the realm of clinical guidelines can thus be
perceived as an extension of the organizational structure
of the medical community in Israel, where the IMA is
comprised of the scientific bodies of physicians and plays
a significant role in scientific activities. Conversely, quality
measurement is an activity of a more administrative
nature. Governments and employers accumulate infor-
mation and process and compare clinical, statistical
and economic data such as mortality and morbidity
rates or volume of clinical procedures in the health
institutions they operate. This systematic process may
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translated into new clinical recommendations, but its
main target is to improve the workings of the health
care system, sometimes by providing an incentive or
imposing a sanction on the healthcare provider.
Moreover, performance and health outcomes do not
depend solely on the activities of physicians. They are
first and foremost dependent on a set of factors that
shape the workings and determine the capacity of the
healthcare system as a whole, such as infrastructure,
equipment, financial investments and organizational
structure. The performance of the individual physician is
derived, among other things, from these factors, and
should be measured and referred to within this context.
Therefore, quality measurement is usually dominated by
the government or by agencies acting on its behalf, and
not by the medical profession, be it scientific societies,
colleges or NMAs (Table 2).
In the table above we tried to examine to what extent
involvement in “traditional” regulatory tasks (licensing
and registration, postgraduate training and physician dis-
ciplinary measures) coincides with participation in the
more innovative activities of quality improvement.
It seems that the general pattern of involvement is
preserved in the group of countries we previously stud-
ied. In the typical corporatist German health care sys-
tem, the medical chambers are heavily involved in all 3
aspects of quality improvement, as they are in the case
of the traditional regulatory tasks. Accordingly, in the
hybrid systems of the Netherlands and Israel, there is a
low to medium degree of involvement. A low to no in-
volvement in quality improvement is demonstrated in
the case of the USA and the UK, where local NMAs are
only marginally, if at all, involved in traditional regula-
tory tasks.
Finally, we would like to briefly address the question
of whether NMAs should take a more active part in add-
itional quality improvement activities.
One of the main conclusions stemming from the inter-
national review performed by Or is that self-regulationTable 2 The scope of compatibility between involvement










Germany Corporatist 3 3
Israel Hybrid 1 2
Netherlands Hybrid 1 1




0 0of clinical care remains a vitally important institution in all
four countries reviewed. By the same token, the experi-
ence of all four countries suggests that self-regulation can
benefit from some external regulation and financial sup-
port from governments in advancing quality improvement
activities. Active collaboration between medical pro-
fessionals and policy makers/managers appears to be
important for any policy. Clinical guidelines provide a
clear example of this conclusion. The review indicates
a somewhat disappointing experience that France has
had with Regulatory Practice Guidelines (Références
Médicales Opposables - RMOs). RMO is a unique ini-
tiative introduced by the French government in the
1990s, which tried to impose mandatory clinical guidelines
on physicians in order to control medical practice. RMOs,
prepared by a governmental agency, did not win the
approval of the majority of French physicians, who viewed
them as an instrument to reduce costs [3]. The physicians’
declining interest in RMOs led to a change in the regu-
lator’s attitude towards the implementation of clinical
guidelines. Control and sanctions gave way to collabora-
tive efforts such as educational programs and campaigns,
in order to disseminate clinical guidelines among physi-
cians and enhance their acceptance by them. These efforts
are usually well received by health professionals and there
is evidence of their effectiveness in the treatment of type
II diabetes and the use of antibiotics [36]. The French
experience suggests that guidelines that do not have
clinical ownership may ultimately fail, especially when
imposed on physicians by the government without
deliberating or collaborating with them.
We believe that the Israeli experience described above
supports Or’s arguments, at least to a certain extent. Wider
collaboration between the Ministry of Health, the em-
ployers and the IMA, as the representative body of the
medical community, may enhance physicians’ confi-
dence in the quality measurement project led by the
Ministry and the HMOs, and would help in creating
wider consensus regarding the method and indicators
chosen. Contrary to France, clinical guidelines in Israel
are prepared and distributed by the medical associations
and the IMA, and as noted previously, they achieve rela-
tively high credibility from Israeli primary care physicians.
Following Or’s work, we cautiously suggest that the fact
that clinical guideline activity in Israel is almost solely in
the hands of the profession, with the assistance and the
organizational approval of the NMA, may have contrib-
uted to the acceptance of the guidelines and positive
perceptions within the medical community. Therefore,
it seems that further involvement of NMAs in quality
improvement, through collaboration with other stake-
holders, namely the government and the employers, can
contribute to the development and implementation of
this important task.
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In this article we set out to explore the role of NMAs in a
key area of medical policy: quality improvement. We have
found that the extent of their participation in quality
improvement activities widely varies. Some NMAs are not
involved in any of the three activities examined, but most
of them participate in them at least to some extent. There
seems to be compatibility between the scope of involve-
ment of NMAs in regulatory tasks and their participation
in quality improvement activities, whereby NMAs in
corporatist health care systems tend to be more involved in
the regulation of both more traditional tasks as well as
in more innovative activities, namely quality improvement.
As to the nature of NMAs’ involvement in this area, it
seems that NMAs are mainly in charge of the regulation
of CME. We speculate that the expertise maintained by
the profession, coupled with the organizational power of
the NMA as a union, is regarded as a useful tool in regu-
lating educational activities in medicine, in the same way
NMAs in many countries are also responsible for post-
graduate training. The issuing of clinical guidelines, on
the other hand, is usually regarded as a typical scientific
activity, less administrative in its nature, whereas quality
measurement is regarded as a distinctive administrative
tool. Therefore these two activities usually rest in the
hands of medical societies and governments respectively.
As mentioned before, it should be noted that this work
is limited to the examination of the formal roles that the
NMAs perform, according to the structured division of
responsibilities between them and other stakeholders. It
does not deal with the scope of implementation of these
activities in practice. Further efforts should be made in
the future in order to examine this subject.
As discussed above, in Israel, the IMA is involved in
the issuing of clinical guidelines in collaboration with its
medical societies and it is also in charge of the regula-
tion of CME credits. We suggest that the fact that acti-
vity regarding clinical guidelines in Israel is almost solely
in the hands of the profession may have contributed to
their acceptance and positive perceptions within the
medical community, although no doubt further efforts
should be made in order to strengthen the position of
the guidelines in the clinical decision making process of
medical practitioners. Therefore, it seems that further
involvement of NMAs in quality improvement through
collaboration with other stakeholders, namely the medical
societies, the government and the employers, can con-
tribute to the development and implementation of this
important task.Endnotes
aThe questionnaire also included questions regarding
the regulation of the medical profession, which was thelocus of our previous work, and questions regarding
public policy which will be discussed separately in
another work.
bThere do not seem to be particular differences between
“developed” and “developing” countries or between OECD
and non-OECD countries regarding the degree of parti-
cipation of NMAs in quality improvement or the kind of
roles they tend to take upon themselves.
cThe voluntary systems include those of Denmark and
Sweden, although in both countries there is no official
CME system. The medical associations and other bodies
hold or approve courses for ongoing medical education,
although there is no formal mechanism of credits.
dIn the United States, while CME is mandatory in the
majority of states, this is not the case throughout the
country.
eIn Britain, CME is sometimes called Continuing Profes-
sional Development (CPD). This term usually refers to an
official study program and is more rigid than CME, which
puts the emphasis on scientific content and is arranged by
the scientific associations.
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